Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
Obesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin an...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/full |
_version_ | 1818344189024272384 |
---|---|
author | Andreia Gameiro Catarina Nascimento Ana Catarina Urbano Jorge Correia Fernando Ferreira |
author_facet | Andreia Gameiro Catarina Nascimento Ana Catarina Urbano Jorge Correia Fernando Ferreira |
author_sort | Andreia Gameiro |
collection | DOAJ |
description | Obesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin and leptin receptor (ObR) levels were investigated in 58 cats with mammary carcinoma and compared with those of healthy animals, as were the expression levels of leptin and ObR in tumor tissues. The results showed that the Free Leptin Index is significantly decreased in cats with mammary carcinoma (p = 0.0006), particularly in those with luminal B and HER2-positive tumors, and that these animals also present significantly lower serum leptin levels (p < 0.0001 and p < 0.005, respectively). Interestingly, ulcerating tumors (p = 0.0005) and shorter disease-free survival (p = 0.0217) were associated to serum leptin levels above 4.17 pg/mL. In contrast, elevated serum ObR levels were found in all cats with mammary carcinoma (p < 0.0001), with levels above 16.89 ng/mL being associated with smaller tumors (p = 0.0118), estrogen receptor negative status (p = 0.0291) and increased serum levels of CTLA-4 (p = 0.0056), TNF-α (p = 0.0025), PD-1 (p = 0.0023), and PD-L1 (p = 0.0002). In tumor samples, leptin is overexpressed in luminal B and triple-negative carcinomas (p = 0.0046), whereas ObR is found to be overexpressed in luminal B tumors (p = 0.0425). Altogether, our results support the hypothesis that serum levels of leptin and ObR can be used as biomarkers of specific feline mammary carcinoma subtypes, and suggests the use of leptin antagonists as a therapeutic tool, reinforcing the utility of the cat as a cancer model. |
first_indexed | 2024-12-13T16:42:31Z |
format | Article |
id | doaj.art-d6d3158360904b919e823d8de1da36a1 |
institution | Directory Open Access Journal |
issn | 2297-1769 |
language | English |
last_indexed | 2024-12-13T16:42:31Z |
publishDate | 2021-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Veterinary Science |
spelling | doaj.art-d6d3158360904b919e823d8de1da36a12022-12-21T23:38:15ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692021-02-01810.3389/fvets.2021.625147625147Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma SubtypesAndreia GameiroCatarina NascimentoAna Catarina UrbanoJorge CorreiaFernando FerreiraObesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin and leptin receptor (ObR) levels were investigated in 58 cats with mammary carcinoma and compared with those of healthy animals, as were the expression levels of leptin and ObR in tumor tissues. The results showed that the Free Leptin Index is significantly decreased in cats with mammary carcinoma (p = 0.0006), particularly in those with luminal B and HER2-positive tumors, and that these animals also present significantly lower serum leptin levels (p < 0.0001 and p < 0.005, respectively). Interestingly, ulcerating tumors (p = 0.0005) and shorter disease-free survival (p = 0.0217) were associated to serum leptin levels above 4.17 pg/mL. In contrast, elevated serum ObR levels were found in all cats with mammary carcinoma (p < 0.0001), with levels above 16.89 ng/mL being associated with smaller tumors (p = 0.0118), estrogen receptor negative status (p = 0.0291) and increased serum levels of CTLA-4 (p = 0.0056), TNF-α (p = 0.0025), PD-1 (p = 0.0023), and PD-L1 (p = 0.0002). In tumor samples, leptin is overexpressed in luminal B and triple-negative carcinomas (p = 0.0046), whereas ObR is found to be overexpressed in luminal B tumors (p = 0.0425). Altogether, our results support the hypothesis that serum levels of leptin and ObR can be used as biomarkers of specific feline mammary carcinoma subtypes, and suggests the use of leptin antagonists as a therapeutic tool, reinforcing the utility of the cat as a cancer model.https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/fullfeline mammary carcinomaleptinleptin receptorfree leptin indexbiomarkers |
spellingShingle | Andreia Gameiro Catarina Nascimento Ana Catarina Urbano Jorge Correia Fernando Ferreira Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes Frontiers in Veterinary Science feline mammary carcinoma leptin leptin receptor free leptin index biomarkers |
title | Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes |
title_full | Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes |
title_fullStr | Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes |
title_full_unstemmed | Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes |
title_short | Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes |
title_sort | serum and tissue expression levels of leptin and leptin receptor are putative markers of specific feline mammary carcinoma subtypes |
topic | feline mammary carcinoma leptin leptin receptor free leptin index biomarkers |
url | https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/full |
work_keys_str_mv | AT andreiagameiro serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes AT catarinanascimento serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes AT anacatarinaurbano serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes AT jorgecorreia serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes AT fernandoferreira serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes |